HeartMate 3 左心室辅助装置支持患者中的主动脉根部血栓形成
本研究纳入2014年11月至2020年8月在一家四级学术医疗中心接受HeartMate 3植入的197例患者,中位随访17.5个月。19例(9.6%)发生主动脉根部血栓形成(ART),ART与死亡、卒中或主动脉瓣干预的复合终点风险升高相关(SHR 3.60,95%CI 1.71-7.56,p=0.001),也与中度及以上主动脉瓣反流相关(SHR 11.1,95%CI 3.60-34.1,p<0.001)。
要点
- 197例HM3患者中19例(9.6%)发生ART,15例(7.6%)发生中度及以上主动脉瓣反流。
- ART与死亡、卒中或主动脉瓣干预复合终点风险升高相关(SHR 3.60,95%CI 1.71-7.56,p=0.001)。
- ART与中度及以上主动脉瓣反流相关(SHR 11.1,95%CI 3.60-34.1,p<0.001),但与死亡或卒中风险无统计学显著升高相关(SHR 2.12,95%CI 0.86-5.22,p=0.10)。
核心结论
- 近10%的HM3患者在装置支持期间发生ART,ART与死亡、卒中或主动脉瓣干预的复合终点以及中度及以上主动脉瓣反流风险升高相关。
研究设计与样本
- 研究纳入2014年11月至2020年8月在一家四级学术医疗中心接受HM3植入的患者,共197例,中位随访17.5个月。
主要发现
- 19例(9.6%)发生ART,15例(7.6%)发生中度及以上主动脉瓣反流。
- ART组与无ART组的基线年龄、性别、种族、植入策略和INTERMACS分级相似。
- ART与死亡、卒中或主动脉瓣干预复合终点风险升高相关(SHR 3.60,95%CI 1.71-7.56,p=0.001)。
- ART与中度及以上主动脉瓣反流相关(SHR 11.1,95%CI 3.60-34.1,p<0.001)。
- ART与死亡或卒中风险无统计学显著升高相关(SHR 2.12,95%CI 0.86-5.22,p=0.10)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Aortic root thrombosis(ART) is a complication of continuous-flow left ventricular assist device therapy. However, the incidence and related complications of ART in HeartMate 3 (HM3) patients remain unknown. METHODS: Patients who underwent HM3 implantation from November 2014 to August 2020 at a quaternary academic medical center were included. Demographics and outcomes were abstracted from the medical record. Echocardiograms and contrast-enhanced computed tomography studies were reviewed to identify patients who developed ART and/or moderate or greater aortic insufficiency (AI) on HM3 support. RESULTS: The study cohort included 197 HM3 patients with a median postimplant follow-up of 17.5 months. Nineteen patients (9.6%) developed ART during HM3 support, and 15 patients (7.6%) developed moderate or greater AI. Baseline age, gender, race, implantation strategy, and INTERMACS classification were similar between the ART and no-ART groups. ART was associated with an increased risk of death, stroke, or aortic valve (AV) intervention (subhazard ratio [SHR] 3.60 [95% confidence interval (CI) 1.71-7.56]; p = 0.001) and moderate or greater AI (SHR 11.1 [CI 3.60-34.1]; p < 0.001) but was not associated with a statistically significantly increased risk of death or stroke on HM3 support (2.12 [0.86-5.22]; p = 0.10). Of the 19 patients with ART, 6 (31.6%) developed moderate or greater AI, necessitating more frequent AV interventions (ART: 5 AV interventions [3 surgical repairs, 1 surgical replacement, 1 transcatheter replacement; 26.3%]; no-ART: 0). CONCLUSIONS: Nearly 10% of HM3 patients developed ART during device support. ART was associated with increased risk of a composite end-point of death, stroke, or AV intervention as well as moderate or greater AI.
引用
- Carey MR, Marshall D, Clerkin K, et al. Aortic Root Thrombosis in patients with HeartMate 3 left ventricular assist device support. J Heart Lung Transplant. 2023. PMID: 37739242. doi:10.1016/j.healun.2023.08.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。